Cogent Biosciences Correlations

COGT Stock

USD 8.03 0.10 1.23%

The current 90-days correlation between Cogent Biosciences and Kura Oncology is 0.18 (i.e., Average diversification). The correlation of Cogent Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cogent Biosciences Correlation With Market

Good diversification

The correlation between Cogent Biosciences and DJI is -0.18 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cogent Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.

Moving together with Cogent Stock

0.8	EQ	Equillium	Pair Corr
0.83	ME	23Andme Holding	Pair Corr
0.84	VALN	Valneva SE ADR	Pair Corr
0.8	DNLI	Denali Therapeutics	Pair Corr
0.77	DNTH	Dianthus Therapeutics	Pair Corr
0.81	DOMH	Dominari Holdings	Pair Corr
0.88	DRRX	Durect	Pair Corr
0.91	DTIL	Precision BioSciences	Pair Corr
0.92	VIGL	Vigil Neuroscience	Pair Corr
0.89	VINC	Vincerx Pharma	Pair Corr
0.92	VKTX	Viking Therapeutics	Pair Corr
0.9	VRCA	Verrica Pharmaceuticals	Pair Corr
0.83	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.76	VRPX	Virpax Pharmaceuticals	Pair Corr
0.75	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Cogent Stock

0.86	VCEL	Vericel Corp Ord	Pair Corr
0.79	VCYT	Veracyte Potential Growth	Pair Corr
0.79	DRTS	Alpha Tau Medical	Pair Corr
0.72	CDIOW	Cardio Diagnostics	Pair Corr
0.69	DMAC	DiaMedica Therapeutics	Pair Corr
0.58	SABSW	SAB Biotherapeutics	Pair Corr
0.82	VRNA	Verona Pharma PLC	Pair Corr
0.8	DYAI	Dyadic International	Pair Corr
0.7	DVAX	Dynavax Technologies	Pair Corr
0.7	SRZNW	Surrozen Warrant	Pair Corr
0.63	VSTM	Verastem	Pair Corr
0.48	KTTAW	Pasithea Therapeutics	Pair Corr
0.4	VYNE	Vyne Therapeutics	Pair Corr
0.39	VTRS	Viatris	Pair Corr

Related Correlations Analysis

	LRMR	KURA	KNSA	CERE	IDYA	ANAB	MGTX	KROS	FIXX	SANA
LRMR		0.9	0.75	0.22	0.91	0.71	0.12	0.9	0.4	0.5	LRMR
KURA	0.9		0.81	0.2	0.89	0.73	-0.06	0.77	0.25	0.58	KURA
KNSA	0.75	0.81		0.25	0.83	0.92	-0.23	0.67	0.06	0.63	KNSA
CERE	0.22	0.2	0.25		0.31	0.15	-0.03	0.2	-0.22	-0.01	CERE
IDYA	0.91	0.89	0.83	0.31		0.75	0.1	0.81	0.2	0.48	IDYA
ANAB	0.71	0.73	0.92	0.15	0.75		-0.25	0.73	0.24	0.67	ANAB
MGTX	0.12	-0.06	-0.23	-0.03	0.1	-0.25		0.11	0.17	-0.31	MGTX
KROS	0.9	0.77	0.67	0.2	0.81	0.73	0.11		0.54	0.43	KROS
FIXX	0.4	0.25	0.06	-0.22	0.2	0.24	0.17	0.54		0.34	FIXX
SANA	0.5	0.58	0.63	-0.01	0.48	0.67	-0.31	0.43	0.34		SANA
	LRMR	KURA	KNSA	CERE	IDYA	ANAB	MGTX	KROS	FIXX	SANA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ANAB	+ 0.92	KNSA
IDYA	+ 0.91	LRMR
KURA	+ 0.9	LRMR
KROS	+ 0.9	LRMR
IDYA	+ 0.89	KURA
IDYA	+ 0.83	KNSA

High negative correlations

SANA	- 0.31	MGTX
MGTX	- 0.25	ANAB
MGTX	- 0.23	KNSA
FIXX	- 0.22	CERE
MGTX	- 0.06	KURA
MGTX	- 0.03	CERE

Risk-Adjusted Indicators

There is a big difference between Cogent Stock performing well and Cogent Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cogent Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LRMR	3.93	(1.04)	0.00	(1.07)	0.00	0.00	8.30	(10.56)	33.48
KURA	2.46	(1.22)	0.00	(11.92)	0.00	0.00	4.47	(5.91)	42.52
KNSA	1.86	(0.52)	0.00	(1.53)	0.00	0.00	2.56	(4.45)	19.13
CERE	0.77	0.08	0.05	(0.73)	0.94	(1.02)	1.91	(1.59)	6.40
IDYA	2.20	(0.45)	0.00	(3.20)	0.00	0.00	4.30	(4.45)	14.50
ANAB	4.24	(0.95)	0.00	(0.67)	0.00	0.00	8.22	(8.03)	44.55
MGTX	3.06	0.51	0.13	0.98	3.23	(3.30)	5.71	(5.87)	23.62
KROS	4.23	(1.65)	0.00	(2.36)	0.00	0.00	6.18	(7.31)	82.94
FIXX	2.82	0.13	0.03	0.27	3.52	(3.25)	5.77	(5.61)	19.43
SANA	7.50	0.79	0.11	0.70	6.52	(10.32)	9.02	(11.88)	176.41

Cogent Biosciences Corporate Management

Rachael MD	VP Development	Profile
Sara Saltzman	VP Affairs	Profile
Jessica MD	Chief Officer	Profile
Brad Fell	Senior Chemistry	Profile
Christi Waarich	Senior Relations	Profile
Brad Barnett	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC